Tanshinone IIA Suppresses the Progression of Lung Adenocarcinoma through Regulating CCNA2-CDK2 Complex and AURKA/PLK1 Pathway

In vitro experimentas focused on the anti-lung adenocarcinoma (LUAD) effects and mechanisms of Tanshinone IIA on LUAD cells via MTT, plate cloning, Annexin V-FITC and PI dual staining, flow cytometry, and western blot assays.